Search

Author/Creator Winston, Alan

44. Do people living with HIV experience greater age advancement than their HIV-negative counterparts?. (1st February 2019)

Authors:
De Francesco, Davide; Wit, Ferdinand W.; Bürkle, Alexander; Oehlke, Sebastian; Kootstra, Neeltje A.; Winston, Alan; Franceschi, Claudio; Garagnani, Paolo; Pirazzini, Chiara; Libert, Claude; Grune, Tilman; Weber, Daniela; Jansen, Eugène H.J.M.; Sabin, Caroline A.; Reiss, Peter
Journal:
AIDS
Issue:
Volume 33:Number 2(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

46. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study. Issue 7 (July 2017)

Authors:
O'Connor, Jemma; Smith, Colette; Lampe, Fiona C; Johnson, Margaret A; Chadwick, David R; Nelson, Mark; Dunn, David; Winston, Alan; Post, Frank A; Sabin, Caroline; Phillips, Andrew N
Journal:
Lancet
Issue:
Volume 4:Issue 7(2017)
Page Start:
e295
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

47. Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study. Issue 5 (21st February 2013)

Authors:
Horner, Patrick J; Wills, Gillian S; Reynolds, Rosy; Johnson, Anne M; Muir, David A; Winston, Alan; Broadbent, Andrew J; Parker, David; McClure, Myra O
Journal:
Sexually transmitted infections
Issue:
Volume 89:Issue 5(2013)
Page Start:
398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

49. Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine. (1st April 2021)

Authors:
Nelson, Mark; Winston, Alan; Hill, Andrew; Mngqibisa, Rosie; Bassa, Ayesha; Orkin, Chloe; Rassool, Mohammed; Rodgers, Anthony; Teal, Valerie; Kumar, Sushma; Teppler, Hedy
Journal:
AIDS
Issue:
Volume 35:Number 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

50. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 12(2022)
Page Start:
1703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗